J.F. Lester

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

Accurate diagnosis of lymphoma on whole-slide histopathology images using deep learning

The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence

Cystic echinococcosis in sub-Saharan Africa

Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells

Guidelines on the radical management of patients with lung cancer

ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer

Global Distribution of Alveolar and Cystic Echinococcosis

The data quality of haematological malignancy ICD-10 diagnoses in a population-based Hospital Discharge Registry

Macrophages in immunoregulation and therapeutics

The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

COVID-19: Global radiation oncology’s targeted response for pandemic preparedness

Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The Danish National Patient Registry: a review of content, data quality, and research potential

Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials

Eicosanoids in Cancer: New Roles in Immunoregulation

Brain metastases: current management and new developments

Bladder cancer

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

Deep learning in histopathology: the path to the clinic

The impact of variant histology on the outcome of bladder cancer treated with curative intent

A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses

Tumour-associated macrophages as treatment targets in oncology

Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable

AKT/PKB Signaling: Navigating the Network

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment

Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Metastatic Prostate Cancer

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK

Small Cell Lung Cancer Treated in Southeast Wales

Bladder Preservation in Small Cell Carcinoma of the Urinary Bladder: An Institutional Experience and Review of the Literature

The clinical impact of expert pathological review on lymphoma management: a regional experience

Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: Results from 4 UK centres

Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study

CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer

Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non–small-cell lung cancer: A Cochrane Review

Hydatid disease of the heart

Third-line Enzalutamide Following Docetaxel and Abiraterone in Metastatic Castrate-resistant Prostate Cancer.

Prostaglandin E₂-mediated adenosinergic effects on CD14⁺cells: Self-amplifying immunosuppression in cancer

Adding abiraterone acetate plus prednisolone (AAP) or docetaxel for patients (pts) with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Directly randomised data from STAMPEDE (NCT00268476)